Sphingotec Revenue and Competitors
Estimated Revenue & Valuation
- Sphingotec's estimated annual revenue is currently $5.4M per year.
- Sphingotec's estimated revenue per employee is $112,000
Employee Data
- Sphingotec has 48 Employees.
- Sphingotec grew their employee count by 0% last year.
Sphingotec's People
| Name | Title | Email/Phone |
|---|
Sphingotec Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Sphingotec?
SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. SphingoTec GmbH was established in 2002 by Dr. Andreas Bergmann was one of the founders of B.R.A.H.M.S. AG. As former Chief Research Officer, he was responsible for the development of the “gold standard†sepsis biomarker Procalcitonin (B.R.A.H.M.S. PCT™).
keywords:N/A
N/A
Total Funding
48
Number of Employees
$5.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sphingotec News
Diagnostics company SphingoTec GmbH (SphingoTec) announced the implementation of two critical care biomarkers to guide the application of a...
The biomarkers are measured with SphingoTec's point of care tests for timely decision making. HENNIGSDORF and BERLIN, GERMANY / ACCESSWIRE /...
SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India. Published: Mar 17, 2022. The collaboration...